ReviewBritish journal of cancer2021

Identifying patients eligible for PARP inhibitor treatment: from NGS-based tests to 3D functional assays.

Pierre-Marie Morice et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.